SPINALCYTE
SpinalCyte, LLC is a regenerative medicine company developing an innovative solution for degenerative disc disease using human dermal fibroblasts. Currently, SpinalCyte holds 32 U.S. and international issued patents and has filed for an additional 48 patents pending. SpinalCyte represents the next generation of medical advancement in cell therapy.
SPINALCYTE
Social Links:
Industry:
Health Care Medical Therapeutics
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.spinalcyte.com
Total Employee:
1+
Status:
Active
Contact:
281-461-6211
Email Addresses:
[email protected]
Technology used in webpage:
Google Maps Google Google Cloud Wix Google Cloud Global Multi-Region Wix Hosted Wix DNS
Similar Organizations
Validus Cellular Therapeutics
Validus Cellular Therapeutics is a developer of therapeutic solutions for treating infectious diseases.
Official Site Inspections
http://www.spinalcyte.com Semrush global rank: 4.7 M Semrush visits lastest month: 1.34 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "SpinalCyte"
FibroGenesis - Crunchbase Company Profile & Funding
FibroGenesis is a regenerative medicine company developing an innovative solution for degenerative disc disease using human dermal fibroblasts. Currently, SpinalCyte holds 32 …See details»
SpinalCyte Company Profile | Management and Employees List
SpinalCyte Profile and History. Chronic Lower Back Pain afflicts millions of people annually in the U.S. Over 7 million of those people suffer from Degenerative Disc Disease. At FibroGenesis …See details»
Fibroblasts | United States | SpinalCyte - FibroGenesis
Our invention is based on using Human Dermal Fibroblasts (HDFs) that are forced to differentiate into chondrocyte-like cells in vivo through mechanical force, and the Intermittent Hydrostatic Pressure (IHP) critical for chondrogenic …See details»
SpinalCyte Company Profile | Management and Employees List
At SpinalCyte, we are the clinical stage world leader in patented fibroblast cell therapy to treat Degenerative Disc Disease. Popular Searches. SpinalCyte LLC. Primary Industries. Business …See details»
SpinalCyte Changes Name To FibroGenesis - Yahoo Finance
Jan 28, 2020 HOUSTON, TX / ACCESSWIRE / January 28, 2020 / SpinalCyte, LLC, today introduced a new company name, FibroGenesis that reflects the expansive intellectual …See details»
SpinalCyte Changes Name To FibroGenesis | SproutNews
SpinalCyte Changes Name To FibroGenesis. Name Change Reflects Broad Clinical Applications of Fibroblasts HOUSTON, TX / ACCESSWIRE / January 28, 2020 / SpinalCyte, LLC, today …See details»
Spinalcyte LLC Company Profile | Houston, TX - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Spinalcyte LLC of Houston, TX. Get the latest business insights from Dun & Bradstreet.See details»
SpinalCyte, LLC Announces New International Patent
Jan 8, 2019 SAN FRANCISCO–(BUSINESS WIRE)–SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc using Human Dermal …See details»
SpinalCyte - Overview, News & Similar companies | ZoomInfo.com
At SpinalCyte, we are the clinical stage world leader in patented fibroblast cell therapy to treat Degenerative Disc Disease. Read more. Is this data correct? Popular Searches SpinalCyte …See details»
Pete O’Heeron, CEO: ‘Through Continued Discovery …
Funded entirely by angel investors, SpinalCyte represents the next generation of medical advancement in cell therapy. The company was incorporated in 2008 and is headquartered in Houston, Texas. Pete O’Heeron, SpinalCyte, LLC CEO, …See details»
News and Events | FibroGenesis SpinalCyte | United States
Sep 28, 2020 SpinalCyte to Present at the 2019 BIO CEO & Investor Conference Read More . January 8, 2019. SpinalCyte Announces New International Patent Read More November 28, …See details»
SpinalCyte Rebrands to FibroGenesis - ORTHOWORLD
Jan 31, 2020 SpinalCyte introduced a new company name, FibroGenesis, reflecting its intellectual property portfolio that includes a treatment for degenerative disc disease (DDD) …See details»
10 things to know about SpinalCyte - Becker's Spine
Apr 17, 2018 6. SpinalCyte holds 25 U.S.- and internationally-issued patents and has filed for an additional 48 patents pending. 7. SpinalCyte CEO and founder Pete O'Heeron holds 11 …See details»
Pipeline | FibroGenesis SpinalCyte | United States
Our cell platform uses human dermal fibroblasts (HDFs) to regenerate tissue and cure chronic disease paths. The human body consists of two cell types with regenerative capabilities, stem …See details»
Articles about SpinalCyte, LLC - BioSpace
Mar 28, 2019 49 articles about SpinalCyte, LLC. SpinalCyte to Present at the 2019 BIO Investor Forum. 10/21/2019. SpinalCyte, LLC, a Texas-based regenerative medicine company focused …See details»
SpinalCyte Changes Name To FibroGenesis - ACCESSWIRE …
Jan 28, 2020 HOUSTON, TX / ACCESSWIRE / January 28, 2020 / SpinalCyte, LLC, today introduced a new company name, FibroGenesis that reflects the expansive intellectual …See details»
SpinalCyte, LLC Announces New International Patent
Jan 8, 2019 SpinalCyte holds 117 U.S. and International Patents pending and issued across a variety of clinical pathways, including disc degeneration, cancer, diabetes, liver failure and …See details»
SpinalCyte Launches Initiative to Highlight Advances in Fibroblast ...
May 15, 2019 About SpinalCyte Based in Houston, Texas, SpinalCyte, LLC, is a regenerative medicine company developing an innovative solution for spinal disc replacement using human …See details»
Phase I/II Clinical Trial Results Positive for SpinalCyte ... - BioSpace
Feb 13, 2018 On behalf of everyone at SpinalCyte, I would like to thank the patients and physicians who participated in our Phase 1/Phase 2 trial and let them know we are committed …See details»
SpinalCyte earns FDA clearance for fibroblast cell therapy: 5 things …
Dec 5, 2018 SpinalCyte received FDA Investigational New Drug clearance for CybroCell, its fibroblast-based therapy to treat degenerative disc disease. Here are five things to know: 1. …See details»